FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

15440111000001103: Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
54764801000001116 Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
54764901000001110 Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
96704301000001115 Levodopa 125mg / Carbidopa 31.25mg / Entacapone 200mg tablets 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

4 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet VMP prescribing status (attribute) Never valid to prescribe as a VMP false Inferred relationship Existential restriction modifier
Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet Has VMP Generic Stalevo 125mg/31.25mg/200mg tablets true Inferred relationship Existential restriction modifier
Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet Has specific active ingredient Carbidopa true Inferred relationship Existential restriction modifier
Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet Has specific active ingredient Entacapone true Inferred relationship Existential restriction modifier
Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Stalevo 125mg/31.25mg/200mg tablets (CST Pharma Ltd) 30 tablet Is a True Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet Inferred relationship Existential restriction modifier
Stalevo 125mg/31.25mg/200mg tablets (Orion Pharma (UK) Ltd) 30 tablet Is a True Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet Inferred relationship Existential restriction modifier
Sastravi 125mg/31.25mg/200mg tablets (Accord Healthcare Ltd) 30 tablet Is a True Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet Inferred relationship Existential restriction modifier
Stanek 125mg/31.25mg/200mg tablets (Teva UK Ltd) 30 tablet Is a True Generic Stalevo 125mg/31.25mg/200mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start